Key result
Thrombolysis reaches only ~31% of STEMI patients in Uzbekistan due to systemic barriers.
Observational (n=1,070)
Yes
Thrombolysis is significantly underutilized in STEMI patients in the Bukhara region of Uzbekistan due to systemic barriers, highlighting the urgent need for standardized protocols, improved infrastructure, and healthcare policy reforms.
Answers are grounded in this paper and cite their sources.
Supports urgent audit of STEMI thrombolysis delivery in Central Asia; leaves open which implementation strategies will safely increase appropriate reperfusion rates.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Aslonova et al. (2026) conducted an observational in Acute Coronary Syndrome (STEMI) (n=1,070). Thrombolysis (Streptokinase) was evaluated on Thrombolysis use rate in STEMI patients. Only 31.3% of patients with STEMI in the Bukhara region of Uzbekistan received thrombolytic therapy, highlighting significant systemic barriers to adequate reperfusion treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: